11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs, accounting for product launches, marketing authorizations, and insurance coverage under publicly funded drug plans in Canada, Europe, and the United States.
The research found that Americans get better and faster access to innovative medicines compared to Europeans and Canadians.